See more : Solid Biosciences Inc. (SLDB) Income Statement Analysis – Financial Results
Complete financial analysis of ChromoCure, Inc. (KKUR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of ChromoCure, Inc., a leading company in the Medical – Specialties industry within the Healthcare sector.
- Crown Equity Holdings Inc. (CRWE) Income Statement Analysis – Financial Results
- Asahi Kogyosha Co., Ltd. (1975.T) Income Statement Analysis – Financial Results
- Corby Spirit and Wine Limited (CRBBF) Income Statement Analysis – Financial Results
- CLASSYS Inc. (214150.KQ) Income Statement Analysis – Financial Results
- Tuktu Resources Ltd. (JAMGF) Income Statement Analysis – Financial Results
ChromoCure, Inc. (KKUR)
Industry: Medical - Specialties
Sector: Healthcare
About ChromoCure, Inc.
ChromoCure, Inc. develops and provides proprietary cancer detection systems. The company offers Chromosomal Scanner Series 200, a cancer detection system to measure the genomic characteristic found in 100% of all cancers and never found in normal cells. It also applies its science and technology to non-toxic and non-invasive approaches to cancer therapy and cure research. The company was formerly known as Cyberhand Technologies International, Inc. and changed its name to ChromoCure, Inc. in June 2009. ChromoCure, Inc. was incorporated in 2001 and is based in Reno, Nevada.
Source: https://incomestatements.info
Category: Stock Reports